Global Intravenous Solution Market: Overview

Intravenous solutions are routinely used in clinical medicine for the replacement and maintenance of body fluids. They are administered to individuals with depletion of body fluids due to dehydration and other medical conditions. Intravenous solutions are administered directly into the veins as they provide rapid relief to individuals undergoing treatment. According to a report published by the World Health Organization (WHO, diarrhea is the second leading cause of death throughout the world, affecting approximately 1.7 billion people. It causes 525,000 deaths every year.

Different types of intravenous solutions, such as isotonic, hypertonic, and hypotonic, are available in the market . Isotonic solutions comprise normal saline (0.9 NaCl) used for extracellular fluid replacement in treating hypernatremia. Hypotonic intravenous solutions comprise 0.45% NaCl and are used as electrolyte replenishers. Hypotonic solutions are used to treat severe cases of dilutional hypernatremia and low levels of sodium. According to a report published by the WHO, approximately 180,000 people suffered from burns and between 20 and 50 million people suffered severe injuries and blood loss due to road accidents in 2017.

Global Intravenous Solution Market: Key Trends

Major drivers of the global intravenous solutions market include increase in the incidence of chronic and acute diseases, rise in the geriatric population, increase in strategic collaborations between manufacturers to enhance their product portfolio and geographical presence, expansion in the pharmaceutical industry, increase in demand for intravenous solutions from developing economies, and increase in health care expenditure. However, factors such as stringent regulatory scenario and high cost of maintenance of fluids are expected to restrain the global intravenous solution market during the forecast period.

Global Intravenous Solution Market: Segmentation

The global intravenous solutions market can be segmented based on product, composition, distribution channel, and geography. In terms of product, the market can be divided into isotonic solutions, hypotonic solutions, and hypertonic solutions. Based on composition, the global intravenous solution market can be classified into 9% normal saline, lactated ringers, 5% dextrose in water, and others. In terms of distribution channel, the global intravenous solution market can be categorized into hospital pharmacies, drug stores, and retail pharmacies.

Global Intravenous Solution Market: Regional Analysis

Based on geography, the global intravenous solutions market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The intravenous solution market in North America is anticipated to dominate the global market during the forecast period, followed by the intravenous solution market in Europe. The major factors contributing to the dominance of the two regions in the global intravenous solution market are increase in the prevalence of chronic diseases, rise in demand for intravenous solutions, and presence of major manufacturers in the region.

The intravenous solution market in Asia Pacific is anticipated to provide lucrative opportunities to manufactures during the forecast period. The market in the region is anticipated to expand at a rapid pace, due to an increase in the patient population, rapid expansion in the pharmaceutical industry in the region, rise in mergers & acquisition, and increase in government initiatives to promote better health care facilities in developing economies of the region.

The intravenous solutions market in Latin America and Middle East & Africa is expected to expand due to an increase in demand for intravenous solutions, adoption of expansion strategy by major manufacturers in the region to increase their geographical presence, and rise in the incidence and prevalence of chronic and acute diseases.

Global Intravenous Solution Market: Competitive Landscape

Major players operating in the global intravenous solutions market are Baxter, Fresenius Kabi, B. Braun Melsungen AG, ICU Medical, Inc., Grifols S.A, Pfizer, and other prominent players. Increase in focus of manufacturers on emerging markets, rise in product approvals, and expansion of product portfolio are anticipated to drive the global intravenous solution market during the forecast period.

The report offers a comprehensive evaluation of the pesto sauces market. It does so via in-depth qualitative insights, historical data, and verifiable projections about pesto sauces market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional pesto sauces markets, technology, types, and applications.

The study is a source of reliable data on:

  • Pesto sauces market segments and sub-segments
  • Pesto sauces market trends and dynamics
  • Supply and demand
  • Pesto sauces market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and pesto sauces market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent pesto sauces market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent pesto sauces market
  • Important changes in pesto sauces market dynamics
  • Pesto sauces market segmentation up to the second or third level
  • Historical, current, and projected size of the pesto sauces market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Pesto sauces market shares and strategies of key players
  • Emerging niche segments and regional pesto sauces markets
  • An objective assessment of the trajectory of the pesto sauces market
  • Recommendations to companies for strengthening their foothold in the pesto sauces market

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent pesto sauces market/vendor-specific changes may take time to reflect in the analysis.

.